Search research articles
Contact Us
Filters
Showing results (11-20 of 68) with videos related to
Page
of 7
Sort By:
Advanced Drug Delivery Reviews
|
October 15, 2020
Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy
Margaret P Manspeaker, Susan N Thomas
Nature Materials
|
October 27, 2023
Lymphatics drain nanoparticles from tumours
Meghan J O'Melia, Susan N Thomas
Nanomaterials (Basel, Switzerland)
|
March 6, 2021
<i>In Situ</i> Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy
Jihoon Kim, David M Francis, Susan N Thomas
American Journal of Physiology. Cell Physiology
|
January 2, 2009
Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells
Susan N Thomas, Ronald L Schnaar, Konstantinos Konstantopoulos
Nature Reviews. Materials
|
June 12, 2020
Material design for lymph node drug delivery
Alex Schudel, David M Francis, Susan N Thomas
Seminars in Immunology
|
November 27, 2021
Innovations in lymph node targeting nanocarriers
Jihoon Kim, Paul A Archer, Susan N Thomas
Acta Biomaterialia
|
February 16, 2019
Augmenting the synergies of chemotherapy and immunotherapy through drug delivery
Jihoon Kim, Margaret P Manspeaker, Susan N Thomas
Journal of Biomedical Materials Research. Part A
|
January 21, 2018
Winner of the society for biomaterials young investigator award for the annual meeting of the society for biomaterials, April 11-14, 2018, Atlanta, GA: S-nitrosated poly(propylene sulfide) nanoparticles for enhanced nitric oxide delivery to lymphatic tissues
Alex Schudel, Lauren F Sestito, Susan N Thomas
Annual Review of Biomedical Engineering
|
March 2, 2016
Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy
Susan N Thomas, Nathan A Rohner, Erin E Edwards
Cancer Immunology, Immunotherapy : CII
|
January 18, 2021
Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC
Meghan J O'Melia, Margaret P Manspeaker, Susan N Thomas
Page
of 7
Search research articles
Search
Showing results (11-20 of 68) with videos related to
Sort By:
Page
of 7
Advanced Drug Delivery Reviews
|
October 15, 2020
Lymphatic immunomodulation using engineered drug delivery systems for cancer immunotherapy
Margaret P Manspeaker, Susan N Thomas
Nature Materials
|
October 27, 2023
Lymphatics drain nanoparticles from tumours
Meghan J O'Melia, Susan N Thomas
Nanomaterials (Basel, Switzerland)
|
March 6, 2021
<i>In Situ</i> Crosslinked Hydrogel Depot for Sustained Antibody Release Improves Immune Checkpoint Blockade Cancer Immunotherapy
Jihoon Kim, David M Francis, Susan N Thomas
American Journal of Physiology. Cell Physiology
|
January 2, 2009
Podocalyxin-like protein is an E-/L-selectin ligand on colon carcinoma cells: comparative biochemical properties of selectin ligands in host and tumor cells
Susan N Thomas, Ronald L Schnaar, Konstantinos Konstantopoulos
Nature Reviews. Materials
|
June 12, 2020
Material design for lymph node drug delivery
Alex Schudel, David M Francis, Susan N Thomas
Seminars in Immunology
|
November 27, 2021
Innovations in lymph node targeting nanocarriers
Jihoon Kim, Paul A Archer, Susan N Thomas
Acta Biomaterialia
|
February 16, 2019
Augmenting the synergies of chemotherapy and immunotherapy through drug delivery
Jihoon Kim, Margaret P Manspeaker, Susan N Thomas
Journal of Biomedical Materials Research. Part A
|
January 21, 2018
Winner of the society for biomaterials young investigator award for the annual meeting of the society for biomaterials, April 11-14, 2018, Atlanta, GA: S-nitrosated poly(propylene sulfide) nanoparticles for enhanced nitric oxide delivery to lymphatic tissues
Alex Schudel, Lauren F Sestito, Susan N Thomas
Annual Review of Biomedical Engineering
|
March 2, 2016
Implications of Lymphatic Transport to Lymph Nodes in Immunity and Immunotherapy
Susan N Thomas, Nathan A Rohner, Erin E Edwards
Cancer Immunology, Immunotherapy : CII
|
January 18, 2021
Tumor-draining lymph nodes are survival niches that support T cell priming against lymphatic transported tumor antigen and effects of immune checkpoint blockade in TNBC
Meghan J O'Melia, Margaret P Manspeaker, Susan N Thomas
Page
of 7